Additionally, at present very little is known about the long-term adverse effects of non-specifically inhibiting EGFR signaling using TKIs, and knowledge of the biological effects of EGFR inhibitors on GBM cells is still incomplete (14). Here, EGFR is linked to glioblastoma.